Edmund Harrigan - May 19, 2023 Form 4 Insider Report for PhaseBio Pharmaceuticals Inc (PHASQ)

Role
Director
Signature
/s/ Jonathan P. Mow, Attorney-in-fact
Stock symbol
PHASQ
Transactions as of
May 19, 2023
Transactions value $
$0
Form type
4
Date filed
5/19/2023, 04:17 PM
Previous filing
Apr 4, 2023
Next filing
Jun 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHASQ Common Stock Options Exercise +3.75K +62.5% 9.75K May 19, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHASQ Restricted Stock Units Options Exercise $0 +3.75K $0.00* 0 May 19, 2023 Common Stock 3.75K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of PhaseBio Pharmaceuticals, Inc. common stock.
F2 The RSUs vested and were delivered to the Reporting Person on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service through such date.